Distribution and function of human ventricular beta adrenergic receptors in congestive heart failure.

[1]  W. Baumgartner,et al.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.

[2]  S. Vatner,et al.  Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure. , 1988, The Journal of clinical investigation.

[3]  F. Schoen,et al.  Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. , 1987, Circulation.

[4]  M. Bristow,et al.  Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. , 1986, Circulation.

[5]  S. Jamieson,et al.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.

[6]  P. Simpson,et al.  Mechanisms and time course of beta 1 adrenoceptor desensitisation in mammalian cardiac myocytes. , 1985, Cardiovascular research.

[7]  S. Vatner,et al.  Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure. , 1985, The Journal of clinical investigation.

[8]  H. Motulsky,et al.  Externalization of beta-adrenergic receptors promoted by myocardial ischemia. , 1985, Science.

[9]  D. Kim,et al.  Mechanisms of beta-adrenergic receptor regulation in cultured chick heart cells. Role of cytoskeleton function and protein synthesis. , 1985, Circulation research.

[10]  T. Smith,et al.  Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect. , 1985, Molecular pharmacology.

[11]  T. K. Harden,et al.  Relationship between an altered membrane form and a low affinity form of the beta-adrenergic receptor occurring during catecholamine-induced desensitization. Evidence for receptor internalization. , 1984, The Journal of biological chemistry.

[12]  G. Stiles,et al.  Translocation and uncoupling of the beta-adrenergic receptor in rat lung after catecholamine promoted desensitization in vivo. , 1984, Endocrinology.

[13]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[14]  E. Braunwald,et al.  Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. , 1981, The New England journal of medicine.

[15]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[16]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[17]  R. Lefkowitz,et al.  A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. , 1980, Molecular pharmacology.

[18]  E. Neer.  The vasopressin-sensitive adenylate cyclase of the rat renal medulla. , 1973, Journal of Biological Chemistry.

[19]  B B Brodie,et al.  A simple, sensitive method for the assay of adenyl cyclase. , 1968, The Journal of pharmacology and experimental therapeutics.

[20]  N. M. Hawkins,et al.  Studies on sodium-potassium-activated adenosinetriphosphatase. IV. Correlation with cation transport sensitive to cardiac glycosides. , 1962, Archives of biochemistry and biophysics.